Oarsman Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
6,669
+115
| +2% | +$4.42K | 0.04% | 205 |
|
|
2025
Q1 | $254K | Buy |
6,554
+26
| +0.4% | +$1.01K | 0.05% | 196 |
|
|
2024
Q4 | $221K | Buy |
6,528
+1,450
| +29% | +$49K | 0.04% | 213 |
|
|
2024
Q3 | $208K | Buy |
+5,078
| New | +$208K | 0.04% | 228 |
|
|
2024
Q2 | – | Sell |
-5,078
| Closed | -$218K | – | 238 |
|
|
2024
Q1 | $218K | Buy |
+5,078
| New | +$218K | 0.05% | 217 |
|